Auf dieser Seite
01NRC Preis
02Momentaufnahme
03Chart
05Über uns
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
26Meine Kennzahlen
NRC National Research Corporation - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 4, 2026
$20,35
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$11,0152-Wochen-Tief
$23,6852-Wochen-Hoch
Marktkapitalisierung (MRQ)
$451M
P/E (TTM)
0.4
EPS (TTM)
$49.75
Umsatz (TTM)
$140M
Ihre Abzeichen
52W-Spanne
$11–$24
Analystenbewertung
BUY
Kursziel
$26
P/E
0.4
ROE
42.0%
Nettogewinnmarge
4.2%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
NRC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$20.35
Marktkapitalisierung (MRQ)
$451M
P/E (TTM)
0.4
EPS (TTM)
$49.75
Umsatz (TTM)
$140M
ROE (TTM)
42.0%
Verschuldungsgrad (MRQ)
14.4
52W-Spanne
$11–$24
NRC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über National Research Corporation - Common Stock Unternehmensübersicht von Wikipedia
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. The company changed its corporate name from National Research Corporation to NRC Health, Inc. in April 2026.
History
National Research Corporation was established in 1981 to provide performance measurement tools and insights for the healthcare industry.
In 1994, the Picker Institute was founded and began development of the Qualisys technology the following year. In 1998, National Research Corporation acquired Healthcare Research Systems, Inc., expanding its offerings in patient experience measurement.
In 2001, the company purchased the Picker Institute's healthcare survey business, enhancing its market presence in patient-centered research. Expansion continued in 2003 with the acquisition of Smaller World Communications, based in Canada.
The company entered the health risk assessment sector in 2005 through the acquisition of Geriatric Health Systems LLC. In 2006, it acquired TGI Group LLC, which led to the creation of The Governance Institute, a resource for healthcare governance education and research.
In 2009, National Research Corporation acquired My InnerView, a firm recognized for its long-term care quality and satisfaction surveys. This was followed in 2010 by the acquisition of OCS HomeCare, a provider of clinical and outcomes analytics for home health and hospice care.
In 2014, the company acquired Digital Assent, the first software platform to enable healthcare organizations to publish physician star ratings based on patient experience data.
In 2016, National Research Corporation rebranded as NRC Health, reflecting a broader commitment to human-centered care and consumer insights.
On February 11, 2020, NRC Health experienced a cyberattack that resulted in the temporary shutdown of its operations and raised concerns about the security of patient data maintained on behalf of its healthcare clients.
Awards
NRC Health is associated with several healthcare recognition programs, including the Consumer Choice Award, the AHCA/NCAL National Quality Award, and Excellence in Action. These programs acknowledge hospitals and long-term care providers based on performance metrics related to patient and resident satisfaction.
In 2010, the company was approved by the Centers for Medicare and Medicaid Services (CMS) as a vendor for the Home Health Consumer Assessment of Healthcare Providers and Systems (HHCAHPS) survey program.
In 2012 and 2013, Modern Healthcare identified NRC Health as the largest patient satisfaction measurement firm in the United States.
Products and services
Products and solutions provided by NRC Health follows the "Eight Dimensions of Patient-Centered Care" philosophy.
Under this strategy, the company provides:
Patient & Family Experience
Resident & Family Experience
Employee Engagement
Physician Engagement
The Consumer Assessment of Healthcare Providers and Systems (CAHPS) program
Market Insights
Healthcare Analytics
Clinical & Outcomes Analytics
Health Risk Assessments
Patient Outreach Programs
Integrated Solutions
The Institutes
CAHPS is a survey system, including HCAHPS, CGCAHPS, HHCAHPS, NHCAHPS, Pediatric HCAHPS, and ICHCAHPS.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealth Care
BrancheHealth Care
Mitarbeiter357
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$137M2016-12-31 → 2025-12-31
EPS$50.002019-12-31 → 2025-12-31
Freier Cashflow·2016-12-31 → 2024-12-31
Nettogewinnmarge4.2%2016-12-31 → 2024-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | NRC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 0.45-Jahres-Durchschnitt ≈21.4 | ≈21.4 | · | · | |
| P/S (TTM) | 3.25-Jahres-Durchschnitt ≈5.6 | ≈5.6 | 2.1 | Überbewertet | |
| K/B (MRQ) | 68.85-Jahres-Durchschnitt ≈14.4 | ≈14.4 | 3.1 | Überbewertet | |
| Kurs / FCF (TTM) | 20.85-Jahres-Durchschnitt ≈31.2 | ≈31.2 | · | · | |
| Kurs / Cashflow (TTM) | 15.35-Jahres-Durchschnitt ≈21.2 | ≈21.2 | 12.8 | Überbewertet | |
| Kurs / Materieller Buchwert (MRQ) | 101.3 | · | · | · | |
| PEG Ratio (PEG-Ratio) | ≈0.0 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | NRC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 10.5%5-Jahres-Durchschnitt ≈29.1% | ≈29.1% | -0.07% | Schwach | |
| Vorgewinnmarge (TTM) | 6.7%5-Jahres-Durchschnitt ≈27.7% | ≈27.7% | 0.46% | Schwach | |
| Nettogewinnmarge (TTM) | 4.2%5-Jahres-Durchschnitt ≈21.1% | ≈21.1% | -2.6% | Schwach | |
| ROA (TTM) | 4.2%5-Jahres-Durchschnitt ≈22.9% | ≈22.9% | 0.70% | Spitzenklasse | |
| ROE (TTM) | 42.0%5-Jahres-Durchschnitt ≈55.8% | ≈55.8% | 10.9% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | NRC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 14.45-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.0 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 0.75-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 0.9 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 13.1 | · | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | NRC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -4.0%5-Jahres-Durchschnitt ≈0.76% | ≈0.76% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -3.2%5-Jahres-Durchschnitt ≈-0.21% | ≈-0.21% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 0.61% | · | · | · | |
| EPS YoY (EPS VjV) | 4707.7%5-Jahres-Durchschnitt ≈935.4% | ≈935.4% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -53.2%5-Jahres-Durchschnitt ≈-18.1% | ≈-18.1% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 240.2%5-Jahres-Durchschnitt ≈74.9% | ≈74.9% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 103.0% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -28.5%5-Jahres-Durchschnitt ≈-15.8% | ≈-15.8% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -20.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | NRC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$384.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Annualisierte Auszahlung≈$0.64
Wachstumsphase≈1
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Sep 25, 2026 | $0,16 | USD | ≈3.3% |
| Jun 26, 2026 | $0,16 | USD | ≈2.9% |
| Mär 27, 2026 | $0,16 | USD | ≈3.3% |
| Dez 26, 2025 | $0,16 | USD | ≈2.8% |
| Sep 26, 2025 | $0,12 | USD | ≈3.6% |
| Jun 27, 2025 | $0,12 | USD | ≈2.9% |
| Mär 28, 2025 | $0,12 | USD | ≈3.7% |
| Dez 27, 2024 | $0,12 | USD | ≈2.8% |
| Sep 27, 2024 | $0,12 | USD | ≈2.1% |
| Jun 28, 2024 | $0,12 | USD | ≈6.4% |
| Mär 27, 2024 | $0,12 | USD | ≈3.8% |
| Dez 28, 2023 | $0,12 | USD | ≈3.8% |
| Sep 28, 2023 | $0,12 | USD | ≈3.9% |
| Sep 15, 2023 | $1,00 | USD | ≈3.5% |
| Jun 29, 2023 | $0,12 | USD | ≈1.4% |
| Mär 30, 2023 | $0,12 | USD | ≈1.7% |
| Dez 29, 2022 | $0,12 | USD | ≈2.3% |
| Sep 29, 2022 | $0,24 | USD | ≈2.1% |
| Jun 29, 2022 | $0,24 | USD | ≈1.9% |
| Mär 30, 2022 | $0,24 | USD | ≈1.5% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
44.0%
Nächster Bericht
Okt 26, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 27, 2026 | $0.31 | $0.14 | 119.2% |
| 31. März 2026 | $0.21 | — | — | |
| 31. Dezember 2025 | $0.16 | — | — | |
| 30. September 2025 | $0.23 | — | — | |
| 30. Juni 2019 | $0.29 | $0.26 | 10.4% | |
| 31. März 2019 | $0.32 | $0.31 | 2.2% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $137M | $143M | $149M | $152M | $148M | $133M | $128M | $120M | $118M | $109M | $102M | $99M | |
| SG&A Expense | $55M | $45M | $47M | $43M | $39M | $34M | $33M | $31M | $30M | $28M | $27M | $25M | |
| Operating Expenses | $115M | $108M | $109M | $105M | $98M | $91M | $85M | $84M | $83M | $78M | $76M | $71M | |
| Operating Income | $23M | $35M | $40M | $47M | $50M | $43M | $43M | $35M | $34M | $31M | $26M | $28M | |
| Interest Expense | · | $3M | $862.0K | $1M | $2M | $2M | $2M | $2M | $82.0K | $190.0K | $220.0K | $305.0K | |
| Interest Income | $111.0K | $125.0K | $820.0K | $168.0K | $14.0K | $18.0K | $37.0K | $62.0K | $96.0K | $47.0K | $60.0K | $83.0K | |
| Other Non-op | $-95.0K | $-34.0K | $-41.0K | $-118.0K | $4.0K | $585.0K | $-462.0K | $885.0K | $50.0K | $302.0K | $1M | $18.0K | |
| Pretax Income | $18M | $33M | $40M | $43M | $49M | $41M | $41M | $35M | $34M | $31M | $27M | $28M | |
| Income Tax | $6M | $8M | $9M | $11M | $11M | $4M | $8M | $5M | $11M | $11M | $10M | $10M | |
| Net Income | $12M | $25M | $31M | $32M | $37M | $37M | $32M | $30M | $23M | $21M | $18M | $18M | |
| EPS (Basic) | $50.00 | $1.05 | $1.26 | $1.28 | $1.47 | $1.48 | $1.30 | · | · | · | · | · | |
| EPS (Diluted) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 | $1.45 | $1.26 | · | · | · | · | · | |
| Shares (Basic) | 22,383,000 | 23,703,000 | 24,540,000 | 24,922,000 | 25,422,000 | 25,170,000 | 24,809,000 | · | · | · | · | · | |
| Shares (Diluted) | 22,396,000 | 23,743,000 | 24,673,000 | 25,052,000 | 25,640,000 | 25,696,000 | 25,653,000 | · | · | · | · | · | |
| EBITDA | · | $35M | $40M | $47M | $50M | · | $43M | $35M | $34M | $31M | $26M | $32M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $4M | $7M | $25M | $54M | $35M | $14M | $13M | $35M | $33M | $42M | $40M | |
| Receivables | $11M | $11M | $12M | $14M | $14M | $14M | $12M | $12M | $15M | $11M | $10M | $8M | |
| Prepaid Expense | $4M | $3M | $4M | $2M | $4M | $3M | $2M | $3M | $2M | $2M | $1M | $1M | |
| Other Current Assets | $520.0K | $692.0K | $940.0K | $1M | $982.0K | $2M | $2M | $224.0K | $35.0K | $35.0K | $34.0K | $994.0K | |
| Current Assets | $20M | $20M | $24M | $44M | $74M | $54M | $29M | $28M | $52M | $47M | $55M | $53M | |
| PP&E (Net) | · | $38M | $28M | $17M | $12M | $12M | $14M | $14M | $12M | $12M | $11M | $12M | |
| PP&E (Gross) | · | $74M | $64M | $51M | $46M | $43M | $42M | $45M | $40M | $38M | $35M | $35M | |
| Accum. Depreciation | · | $35M | $36M | $34M | $33M | $31M | $29M | $31M | $28M | $26M | $23M | $23M | |
| Goodwill | $66M | $66M | $62M | $62M | $62M | $57M | $58M | $58M | $58M | $58M | $58M | $58M | |
| Intangibles | $2M | $3M | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $3M | $4M | $5M | |
| Other Non-current Assets | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $768.0K | $293.0K | $234.0K | |
| Total Assets | $135M | $133M | $122M | $130M | $158M | $133M | $111M | $108M | $127M | $121M | $128M | $130M | |
| Accounts Payable | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $613.0K | $593.0K | $765.0K | $614.0K | $830.0K | |
| Accrued Liabilities | $3M | $5M | $5M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Short-term Debt | $4M | $5M | $7M | $4M | $4M | $4M | $4M | $4M | $1M | $3M | $2M | $2M | |
| Current Liabilities | $37M | $36M | $36M | $33M | $40M | $32M | $38M | $47M | $32M | $32M | $44M | $28M | |
| Capital Leases | $744.0K | $1M | $2M | · | · | · | · | $676.0K | $87.0K | $110.0K | $103.0K | $167.0K | |
| Deferred Tax | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $6M | $4M | $5M | $6M | $7M | |
| Other Non-current Liabilities | $3M | $4M | $4M | $2M | $3M | $4M | $2M | $1M | $935.0K | $777.0K | $575.0K | $541.0K | |
| Total Liabilities | $121M | $101M | $73M | $58M | $72M | $69M | $78M | $89M | $37M | $38M | $54M | $42M | |
| Long-term Debt | $79M | · | $37M | $22M | $27M | $31M | $34M | $38M | $1M | $4M | $6M | $8M | |
| Total Debt | · | $63M | $7M | $4M | $4M | · | $34M | $38M | $2M | $6M | $8M | $10M | |
| Common Stock | $32.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $30.0K | $30.0K | $26.0K | · | · | · | |
| Retained Earnings | $-17M | $-17M | $-31M | $-25M | $-36M | $-61M | $-93M | $-106M | $78M | $72M | $65M | $74M | |
| Treasury Stock | $153M | $132M | $99M | $78M | $50M | $44M | $34M | $29M | $37M | $33M | $32M | $30M | |
| AOCI | · | · | · | · | · | · | · | · | · | $-3M | $-3M | $-773.0K | |
| Stockholders' Equity | $14M | $31M | $49M | $72M | $85M | $64M | $33M | $19M | $90M | $83M | $74M | $88M | |
| Liabilities + Equity | $135M | $133M | $122M | $130M | $158M | $133M | $111M | $108M | $127M | $121M | $128M | $130M | |
| Shares Outstanding | 22,637,252 | 23,083,116 | 24,219,887 | 24,628,173 | 25,361,409 | 25,390,968 | 24,947,500 | 24,800,796 | 20,936,703 | · | · | · |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $6M | $6M | · | · | · | $6M | $5M | $5M | $4M | $4M | $4M | |
| Stock-based Comp | $3M | $284.0K | $935.0K | $1M | $623.0K | $680.0K | $1M | $2M | $2M | $2M | $1M | $742.0K | |
| Deferred Tax | $2M | $-664.0K | $-1M | $-2M | $-277.0K | $-134.0K | $1M | $1M | $-684.0K | $798.0K | $-1M | $107.0K | |
| Amort. of Intangibles | $389.0K | $264.0K | $140.0K | $180.0K | $320.0K | $318.0K | $374.0K | $662.0K | $610.0K | $654.0K | $995.0K | $876.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Operating Cash Flow | $26M | $35M | $38M | $36M | $46M | $41M | $41M | $40M | $28M | $27M | $22M | $26M | |
| CapEx | $11M | $15M | $16M | $10M | $6M | $4M | $5M | $6M | $5M | $4M | $3M | $2M | |
| Investing Cash Flow | $-11M | $-20M | $-16M | $-10M | $-9M | $-4M | $-5M | $-6M | $-6M | $-4M | $-1M | $-6M | |
| Stock Repurchased | $20M | $31M | $19M | $28M | $4M | · | · | · | · | · | $2M | · | |
| Net Stock Activity | · | $-31M | $-19M | $-28M | $-4M | · | · | · | · | · | $-2M | · | |
| Dividends Paid | $11M | $11M | $36M | $21M | $9M | $11M | $31M | $17M | $17M | $29M | $10M | · | |
| Financing Cash Flow | $-16M | $-17M | $-41M | $-56M | $-18M | $-16M | $-36M | $-54M | $-21M | $-33M | $-17M | $-2M | |
| Net Change in Cash | $-94.0K | $-2M | $-18M | $-29M | $20M | $21M | $526.0K | $-22M | $2M | $-9M | $2M | $18M | |
| Taxes Paid | · | $8M | $9M | $12M | $11M | $5M | $7M | $3M | $13M | $10M | $9M | · | |
| Free Cash Flow | · | $19M | $22M | $26M | $41M | · | $36M | $34M | $24M | $23M | $19M | $24M | |
| Levered FCF | · | $17M | $22M | $26M | $40M | · | $35M | $33M | $23M | $23M | $19M | $24M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 24.6% | 27.0% | 30.7% | 34.0% | · | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 28.6% | |
| Net Margin | · | 17.3% | 20.8% | 21.0% | 25.3% | · | 25.3% | 25.1% | 19.5% | 18.8% | 17.2% | 18.4% | |
| Pretax Margin | · | 22.9% | 26.9% | 28.2% | 32.9% | · | 31.7% | 29.0% | 29.2% | 28.7% | 26.7% | 28.4% | |
| EBITDA Margin | · | 24.6% | 27.0% | 30.7% | 34.0% | · | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 32.5% | |
| ROA | · | 19.4% | 24.5% | 22.1% | 25.8% | · | 29.6% | 25.5% | 18.5% | 16.5% | 13.6% | 15.1% | |
| ROE | · | 75.2% | 58.0% | 45.5% | 44.5% | · | 104.8% | 122.1% | 26.6% | 26.1% | 21.7% | 22.8% | |
| ROIC | · | 28.4% | 55.2% | 45.2% | 43.2% | · | 51.3% | 53.6% | 24.8% | 22.9% | 20.7% | 18.6% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.5 | 0.7 | 1.3 | 1.8 | · | 0.8 | 0.6 | 1.6 | 1.5 | 1.3 | 1.9 | |
| Quick Ratio | · | 0.4 | 0.5 | 1.2 | 1.7 | · | 0.7 | 0.5 | 1.5 | 1.4 | 1.2 | 1.7 | |
| Debt / Equity | · | 2.0 | 0.1 | 0.1 | 0.1 | · | 1.0 | 2.0 | 0.0 | 0.1 | 0.1 | 0.1 | |
| LT Debt / Equity | · | 1.9 | · | · | · | · | 0.9 | 1.8 | · | 0.0 | 0.0 | 0.1 | |
| Interest Coverage | · | 13.6 | 46.5 | 38.5 | 30.2 | · | 20.6 | 23.3 | 417.3 | 164.2 | 120.2 | 92.8 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 1.2 | 1.1 | 1.0 | · | 1.2 | 1.0 | 0.9 | 0.9 | 0.8 | 0.8 | |
| Receivables Turnover | · | 12.2 | 11.1 | 10.8 | 10.7 | · | 10.9 | 9.0 | 9.7 | 10.6 | 11.4 | 10.3 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.36 | $2.02 | $2.92 | $3.36 | · | $1.32 | $0.77 | · | · | · | · | |
| Revenue / Share | · | $6.03 | $6.02 | $6.05 | $5.77 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $1.46 | $1.54 | $1.45 | $1.81 | · | · | · | · | · | · | · | |
| Cash / Share | · | $0.18 | $0.27 | $1.02 | $2.14 | · | $0.54 | $0.52 | · | · | · | · | |
| Dividend / Share | $0.52 | $0.48 | $1.48 | $0.84 | $0.48 | $0.21 | $0.78 | · | · | · | · | · | |
| EPS (TTM) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 | $1.45 | $1.26 | $2.28 | $2.28 | $2.28 | $2.28 | $2.28 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.0% | -3.7% | -2.0% | 2.4% | 11.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -3.2% | -1.1% | 3.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.61% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4707.7% | -16.8% | -1.6% | -13.0% | 0.69% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 240.2% | -10.7% | -4.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 103.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -53.2% | -20.0% | -2.6% | -15.1% | 0.55% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -28.5% | -12.9% | -6.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -20.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 0.86% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $137M | $143M | $149M | $152M | $148M | $133M | $128M | $120M | $118M | $109M | $102M | $99M | |
| Net Income TTM | $12M | $25M | $31M | $32M | $37M | $37M | $32M | $30M | $23M | $21M | $18M | $18M | |
| Market Cap | · | $407M | $958M | $919M | $1.05B | · | $1.65B | $946M | · | · | · | · | |
| Enterprise Value | · | $466M | $959M | $898M | $1.00B | · | $1.67B | $971M | · | · | · | · | |
| P/E | 0.4 | 17.0 | 31.6 | 29.4 | 28.4 | 29.5 | 52.3 | 16.7 | 16.4 | 8.3 | 7.0 | 6.1 | |
| P/S | · | 2.8 | 6.4 | 6.1 | 7.1 | · | 12.9 | 7.9 | · | · | · | · | |
| P/B | · | 13.0 | 19.6 | 12.8 | 12.3 | · | 50.0 | 49.6 | · | · | · | · | |
| P / Tangible Book | · | · | · | 104.3 | 48.0 | 192.1 | · | · | · | · | · | · | |
| P / Cash Flow | · | 11.8 | 25.1 | 25.3 | 22.7 | · | 40.2 | 23.7 | · | · | · | · | |
| P / FCF | · | 21.2 | 42.9 | 34.8 | 25.8 | · | 45.4 | 27.9 | · | · | · | · | |
| EV / EBITDA | · | 13.2 | 23.9 | 19.3 | 20.0 | · | 38.7 | 27.5 | · | · | · | · | |
| EV / FCF | · | 24.3 | 42.9 | 34.0 | 24.6 | · | 45.9 | 28.7 | · | · | · | · | |
| EV / Revenue | · | 3.3 | 6.5 | 5.9 | 6.8 | · | 13.0 | 8.1 | · | · | · | · | |
| Dividend Yield | · | 2.8% | 3.8% | 2.3% | 0.87% | · | 1.9% | 1.8% | · | · | · | · | |
| Earnings Yield | 266.4% | 5.9% | 3.2% | 3.4% | 3.5% | 3.4% | 1.9% | 6.0% | 6.1% | 12.0% | 14.2% | 16.3% | |
| Payout Ratio | · | 46.2% | 117.4% | 65.9% | 24.4% | · | 96.6% | 56.1% | 73.5% | 139.2% | 57.1% | · | |
| Annual Payout | $11M | $11M | $36M | $21M | $9M | $11M | $31M | $17M | $17M | $29M | $10M | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $35M | $35M | $35M | $35M | $34M | $34M | $37M | $36M | $35M | $35M | $38M | $38M | $36M | $36M | $38M | $38M | |
| SG&A Expense | $23M | $13M | $14M | $12M | $18M | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $12M | $11M | $11M | |
| Operating Expenses | $39M | $29M | $31M | $27M | $32M | $25M | $27M | $28M | $26M | $27M | $26M | $28M | $27M | $27M | $26M | $27M | |
| Operating Income | $-3M | $6M | $5M | $8M | $2M | $9M | $10M | $8M | $9M | $9M | $12M | $10M | $9M | $9M | $12M | $11M | |
| Interest Expense | · | · | · | $1M | $1M | $899.0K | · | $706.0K | $555.0K | $605.0K | · | $160.0K | $192.0K | $241.0K | $286.0K | $288.0K | |
| Interest Income | $20.0K | $35.0K | $30.0K | $41.0K | $21.0K | $19.0K | $22.0K | $34.0K | $25.0K | $44.0K | $41.0K | $256.0K | $273.0K | $250.0K | $134.0K | $15.0K | |
| Other Non-op | $2.0K | $30.0K | $-61.0K | $-45.0K | $4.0K | $7.0K | $-6.0K | $-12.0K | $-11.0K | $-5.0K | $-13.0K | $-12.0K | $-2.0K | $-14.0K | $-49.0K | $11.0K | |
| Pretax Income | $-5M | $4M | $3M | $6M | $581.0K | $8M | $9M | $7M | $8M | $8M | $11M | $10M | $9M | $9M | $9M | $11M | |
| Income Tax | $-1M | $1M | $1M | $2M | $687.0K | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $3M | |
| Net Income | $-3M | $3M | $2M | $4M | $-106.0K | $6M | $7M | $6M | $6M | $6M | $9M | $8M | $7M | $7M | $7M | $8M | |
| EPS (Basic) | $-0.15 | $0.14 | $49.58 | $0.18 | $-0.01 | $0.25 | $0.28 | $0.24 | $0.26 | $0.27 | $0.36 | $0.32 | $0.30 | $0.28 | $0.27 | $0.34 | |
| EPS (Diluted) | $-0.15 | $0.14 | $49.58 | $0.18 | $-0.01 | $0.25 | $0.27 | $0.24 | $0.26 | $0.27 | $0.36 | $0.32 | $0.29 | $0.28 | $0.27 | $0.33 | |
| Shares (Basic) | 22,009,000 | 21,799,000 | · | 22,130,000 | 22,658,000 | 22,972,000 | · | 23,721,000 | 23,871,000 | 23,868,000 | · | 24,560,000 | 24,578,000 | 24,585,000 | · | 24,716,000 | |
| Shares (Diluted) | 22,009,000 | 21,911,000 | · | 22,130,000 | 22,658,000 | 22,974,000 | · | 23,745,000 | 23,915,000 | 23,963,000 | · | 24,695,000 | 24,716,000 | 24,738,000 | · | 24,847,000 | |
| EBITDA | $-3M | $6M | · | $8M | $2M | $9M | · | $8M | $9M | $9M | · | $10M | $9M | $9M | · | $11M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $3M | $4M | $2M | $5M | $3M | $4M | $3M | $485.0K | $2M | · | $4M | $22M | $24M | · | $28M | |
| Receivables | $9M | $11M | $11M | $13M | $12M | $11M | $11M | $11M | $10M | $11M | · | $14M | $12M | $14M | · | $15M | |
| Prepaid Expense | $5M | $6M | $4M | $4M | $5M | $6M | $3M | $5M | $5M | $6M | · | $6M | $6M | $6M | · | $4M | |
| Other Current Assets | $431.0K | $461.0K | $520.0K | $973.0K | $2M | $588.0K | $692.0K | $664.0K | $1M | $777.0K | · | $369.0K | $834.0K | $1M | · | $1M | |
| Current Assets | $23M | $20M | $20M | $20M | $25M | $20M | $20M | $21M | $17M | $20M | · | $25M | $41M | $45M | · | $49M | |
| PP&E (Net) | · | · | · | $41M | $42M | $40M | · | $36M | $34M | $32M | · | $26M | $23M | $19M | · | $16M | |
| PP&E (Gross) | · | · | · | $82M | $81M | $77M | · | $76M | $72M | $69M | · | $63M | $59M | $54M | · | $52M | |
| Accum. Depreciation | · | · | · | $41M | $38M | $37M | · | $40M | $39M | $37M | · | $37M | $36M | $35M | · | $36M | |
| Goodwill | $66M | $66M | $66M | $66M | $66M | $66M | $66M | $66M | $62M | $62M | $62M | $62M | $62M | $62M | · | $62M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $3M | $3M | $3M | $2M | $2M | $3M | $4M | $6M | $2M | $3M | · | $4M | $5M | $4M | · | $3M | |
| Total Assets | $136M | $135M | $135M | $136M | $141M | $135M | $133M | $132M | $119M | $121M | · | $120M | $134M | $134M | · | $135M | |
| Accounts Payable | $1M | $2M | $1M | $1M | $1M | $2M | $1M | $3M | $1M | $2M | · | $1M | $2M | $1M | · | $1M | |
| Accrued Liabilities | $4M | $3M | $3M | $4M | $6M | $5M | $5M | $6M | $5M | $6M | · | $5M | $4M | $4M | · | $5M | |
| Short-term Debt | $4M | $4M | $4M | $4M | $4M | $3M | $5M | $4M | $8M | $8M | · | $5M | $5M | $5M | · | $4M | |
| Current Liabilities | $35M | $38M | $37M | $39M | $36M | $38M | $36M | $44M | $46M | $49M | · | $41M | $34M | $36M | · | $41M | |
| Capital Leases | · | · | $744.0K | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $6M | $6M | $6M | $3M | $4M | $5M | $4M | $4M | $4M | $4M | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | · | $3M | $2M | $2M | · | $2M | |
| Total Liabilities | $130M | $121M | $121M | $121M | $120M | $106M | $101M | $97M | $79M | $84M | · | $62M | $56M | $60M | · | $67M | |
| Long-term Debt | $90M | · | · | · | · | · | · | $49M | $33M | $35M | · | $19M | $20M | $21M | · | $23M | |
| Total Debt | $94M | $78M | · | $80M | $81M | $62M | · | $49M | $33M | $35M | · | $5M | $5M | $5M | · | $4M | |
| Common Stock | $32.0K | $32.0K | $32.0K | $32.0K | $32.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | · | $31.0K | $31.0K | $31.0K | · | $31.0K | |
| Retained Earnings | $-25M | $-18M | $-17M | $-15M | $-17M | $-14M | $-17M | $-21M | $-24M | $-27M | · | $-36M | $-17M | $-21M | · | $-29M | |
| Treasury Stock | $162M | $154M | $153M | $152M | $143M | $137M | $132M | $125M | $116M | $116M | · | $82M | $82M | $80M | · | $76M | |
| Stockholders' Equity | $7M | $13M | $14M | $14M | $21M | $30M | $31M | $35M | $40M | $37M | $49M | $58M | $78M | $75M | $72M | $68M | |
| Liabilities + Equity | $136M | $135M | $135M | $136M | $141M | $135M | $133M | $132M | $119M | $121M | · | $120M | $134M | $134M | · | $135M | |
| Shares Outstanding | 22,139,315 | 22,536,696 | 22,637,252 | 22,657,421 | 23,103,685 | 22,785,421 | 23,083,116 | 23,476,040 | 23,871,257 | 23,877,315 | · | 24,562,068 | 24,567,092 | 24,599,815 | · | 24,691,246 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | · | $1M | |
| Stock-based Comp | $7M | $2M | $2M | $925.0K | $307.0K | $171.0K | $188.0K | $189.0K | $-57.0K | $-36.0K | $258.0K | $68.0K | $305.0K | $304.0K | $290.0K | $291.0K | |
| Deferred Tax | $0 | $-36.0K | $3M | $-48.0K | $-2M | $2M | $-546.0K | $18.0K | $110.0K | $-246.0K | $-400.0K | $29.0K | $-373.0K | $-377.0K | $36.0K | $-486.0K | |
| Operating Cash Flow | $1M | $7M | $7M | $14M | $-1M | $7M | $6M | $9M | $7M | $12M | $12M | $10M | $9M | $8M | $8M | $10M | |
| CapEx | $1M | $2M | $1M | $4M | $3M | $3M | $4M | $2M | $5M | $4M | $4M | $4M | $4M | $3M | $2M | $4M | |
| Investing Cash Flow | $-1M | $-2M | $-1M | $-4M | $-3M | $-3M | $-4M | $-6M | $-5M | $-4M | $-4M | $-4M | $-4M | $-3M | $-2M | $-4M | |
| Stock Repurchased | $8M | $2M | $1.0K | $9M | $6M | $5M | $7M | $9M | $0 | $15M | $15M | $309.0K | $2M | $2M | $2M | $3M | |
| Net Stock Activity | · | $-2M | · | · | · | $-5M | · | · | · | $-15M | · | · | · | $-2M | · | · | |
| Dividends Paid | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $28M | $3M | $3M | $6M | $6M | |
| Financing Cash Flow | $718.0K | $-7M | $-4M | $-13M | $7M | $-5M | $-1M | $-17.0K | $-3M | $-13M | $-5M | $-24M | $-6M | $-6M | $-10M | $-10M | |
| Net Change in Cash | $780.0K | $-2M | $2M | $-3M | $3M | $-2M | $772.0K | $3M | $-1M | $-5M | $3M | $-19M | $-1M | $-1M | $-3M | $-5M | |
| Taxes Paid | · | · | · | $373.0K | $3M | $80.0K | $2M | $2M | $4M | $78.0K | $2M | $2M | $4M | $27.0K | $3M | $3M | |
| Free Cash Flow | · | $5M | · | · | · | $4M | · | · | · | $8M | · | · | · | $5M | · | · | |
| Levered FCF | · | · | · | · | · | $3M | · | · | · | $7M | · | · | · | $4M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -9.2% | 16.0% | · | 22.4% | 4.7% | 25.6% | · | 22.3% | 25.3% | 24.8% | · | 26.2% | 25.9% | 24.7% | · | 29.5% | |
| Net Margin | -9.3% | 9.3% | · | 11.9% | -0.31% | 17.2% | · | 15.9% | 17.6% | 18.0% | · | 20.8% | 20.1% | 19.1% | · | 22.0% | |
| Pretax Margin | -12.8% | 12.6% | · | 18.1% | 1.7% | 23.0% | · | 20.4% | 23.8% | 23.2% | · | 26.5% | 26.1% | 24.7% | · | 28.8% | |
| EBITDA Margin | -9.2% | 16.0% | · | 22.4% | 4.7% | 25.6% | · | 22.3% | 25.3% | 24.8% | · | 26.2% | 25.9% | 24.7% | · | 29.5% | |
| ROA | -2.4% | 2.4% | · | 3.1% | -0.08% | 4.5% | · | 4.5% | 4.9% | 5.0% | · | 6.2% | 5.4% | 4.9% | · | 5.7% | |
| ROE | -23.5% | 14.9% | · | 16.9% | -0.34% | 17.4% | · | 12.3% | 10.5% | 11.4% | · | 12.5% | 9.9% | 8.9% | · | 11.0% | |
| ROIC | -2.3% | 4.5% | · | 5.4% | -0.28% | 7.0% | · | 7.5% | 9.0% | 9.4% | · | 12.5% | 8.8% | 8.8% | · | 11.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.5 | · | 0.5 | 0.7 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.6 | 1.2 | 1.3 | · | 1.2 | |
| Quick Ratio | 0.4 | 0.3 | · | 0.4 | 0.5 | 0.4 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 1.0 | 1.1 | · | 1.1 | |
| Debt / Equity | 14.4 | 5.8 | · | 5.6 | 3.8 | 2.1 | · | 1.4 | 0.8 | 0.9 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 13.1 | 5.5 | · | 5.3 | 3.6 | 2.0 | · | 1.3 | 0.6 | 0.7 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | 5.3 | 1.5 | 9.6 | · | · | · | 14.5 | · | 62.2 | 48.8 | 37.4 | · | 38.6 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 3.3 | 3.1 | · | 2.9 | 3.0 | 3.0 | · | 2.8 | 3.2 | 2.8 | · | 2.5 | 2.9 | 2.4 | · | 2.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.30 | $0.60 | · | $0.63 | $0.92 | $1.30 | · | $1.47 | $1.68 | $1.55 | · | $2.36 | $3.16 | $3.04 | · | $2.74 | |
| Revenue / Share | $1.61 | $1.59 | · | $1.56 | $1.50 | $1.46 | · | $1.51 | $1.46 | $1.47 | · | $1.54 | $1.46 | $1.47 | · | $1.52 | |
| Cash Flow / Share | · | $0.33 | · | · | · | $0.29 | · | · | · | $0.50 | · | · | · | $0.31 | · | · | |
| Cash / Share | $0.15 | $0.11 | · | $0.10 | $0.23 | $0.11 | · | $0.15 | $0.02 | $0.07 | · | $0.16 | $0.92 | $0.96 | · | $1.15 | |
| Dividend / Share | $0.16 | $0.16 | $0.16 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $1.12 | $0.12 | $0.12 | $0.12 | $0.24 | |
| EPS (TTM) | $49.75 | $49.89 | · | $0.69 | $0.75 | $1.02 | · | $1.13 | $1.21 | $1.24 | · | $1.16 | $1.17 | $1.21 | · | $1.37 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $140M | $139M | · | $139M | $140M | $141M | · | $144M | $146M | $147M | · | $149M | $148M | $150M | · | $152M | |
| Net Income TTM | $6M | $9M | · | $16M | $18M | $24M | · | $27M | $29M | $30M | · | $29M | $29M | $30M | · | $35M | |
| Market Cap | $478M | $383M | · | $290M | $388M | $292M | · | $537M | $548M | $946M | · | $1.09B | $1.07B | $1.07B | · | $983M | |
| Enterprise Value | $568M | $458M | · | $367M | $464M | $351M | · | $582M | $581M | $979M | · | $1.09B | $1.05B | $1.05B | · | $959M | |
| P/E | 0.4 | 0.3 | · | 18.5 | 22.4 | 12.5 | · | 20.2 | 19.0 | 31.9 | · | 38.2 | 37.2 | 36.0 | · | 29.1 | |
| P/S | 3.4 | 2.8 | · | 2.1 | 2.8 | 2.1 | · | 3.7 | 3.7 | 6.4 | · | 7.3 | 7.2 | 7.2 | · | 6.5 | |
| P/B | 72.9 | 28.4 | · | 20.2 | 18.2 | 9.8 | · | 15.5 | 13.6 | 25.6 | · | 18.8 | 13.7 | 14.3 | · | 14.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 73.2 | 93.3 | · | 218.3 | |
| P / Cash Flow | · | 53.3 | · | · | · | 43.9 | · | · | · | 78.6 | · | · | · | 138.1 | · | · | |
| EV / Revenue | 4.1 | 3.3 | · | 2.6 | 3.3 | 2.5 | · | 4.0 | 4.0 | 6.6 | · | 7.3 | 7.1 | 7.0 | · | 6.3 | |
| Dividend Yield | 2.7% | 3.1% | · | 3.8% | 2.9% | 3.9% | · | 2.2% | 6.6% | 3.8% | · | 3.6% | 1.7% | 1.9% | · | 1.8% | |
| Earnings Yield | 230.6% | 293.8% | · | 5.4% | 4.5% | 8.0% | · | 4.9% | 5.3% | 3.1% | · | 2.6% | 2.7% | 2.8% | · | 3.4% | |
| Payout Ratio | · | 112.5% | · | · | · | 47.9% | · | · | · | 45.7% | · | · | · | 42.4% | · | · | |
| Annual Payout | $13M | $12M | · | $11M | $11M | $11M | · | $12M | $36M | $36M | · | $39M | $18M | $21M | · | $18M |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $137M | $143M | $149M | $152M | $148M |
| Betriebsgewinnmarge % | · | 24.6% | 27.0% | 30.7% | 34.0% |
| Nettoergebnis | $12M | $25M | $31M | $32M | $37M |
| Verwässerte EPS | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | 2.0 | 0.1 | 0.1 | 0.1 |
| Liquiditätsgrad | · | 0.5 | 0.7 | 1.3 | 1.8 |
| Quick Ratio | · | 0.4 | 0.5 | 1.2 | 1.7 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | $19M | $22M | $26M | $41M |
Institutionelle Eigentümer (13F) 134 Einreicher · $237.0M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
134
Gehaltener Wert
$237.0M
Neue Positionen
18
Geschlossene Positionen
11
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 18 (-1 vs. Vorquartal) | 11 (+1 vs. Vorquartal) | 43 (+14 vs. Vorquartal) | 39 (-15 vs. Vorquartal) | -77K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $43.797.714 | 2.030.492 | 18,48% | Aktien |
| BlackRock, Inc. | $22.893.428 | 1.061.355 | 9,66% | Aktien |
| MORGAN STANLEY | $18.534.465 | 859.269 | 7,82% | Aktien |
| VANGUARD GROUP INC | $15.604.984 | 831.379 | 6,58% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $14.377.570 | 666.554 | 6,07% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $10.595.956 | 491.228 | 4,47% | Aktien |
| Willis Investment Counsel | $9.378.312 | 434.785 | 3,96% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $9.062.880 | 420.056 | 3,82% | Aktien |
| FARMERS & MERCHANTS INVESTMENTS INC | $7.132.099 | 330.649 | 3,01% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $7.018.533 | 325.384 | 2,96% | Aktien |
| STATE STREET CORP | $6.483.381 | 298.384 | 2,74% | Aktien |
| HEARTLAND ADVISORS INC | $6.471.000 | 300.000 | 2,73% | Aktien |
| Bank of New York Mellon Corp | $5.440.710 | 252.235 | 2,30% | Aktien |
| NORTHERN TRUST CORP | $5.138.900 | 238.243 | 2,17% | Aktien |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $4.053.434 | 187.920 | 1,71% | Aktien |
| WELLS FARGO & COMPANY/MN | $3.874.460 | 179.623 | 1,63% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $2.635.976 | 122.206 | 1,11% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.444.140 | 113.312 | 1,03% | Aktien |
| Northwest & Ethical Investments L.P. | $2.208.121 | 102.370 | 0,93% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.096.604 | 97.200 | 0,88% | Aktien |
| GOLDMAN SACHS GROUP INC | $2.087.458 | 96.776 | 0,88% | Aktien |
| JANE STREET GROUP, LLC | $1.884.679 | 87.375 | 0,80% | Aktien |
| FIFTH THIRD BANCORP | $1.841.475 | 85.372 | 0,78% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.789.145 | 82.946 | 0,75% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.762.808 | 81.725 | 0,74% | Aktien |
| COMERICA BANK | $1.687.723 | 89.916 | 0,71% | Aktien |
| Linden Thomas Advisory Services, LLC | $1.679.311 | 77.854 | 0,71% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.675.644 | 77.684 | 0,71% | Aktien |
| Quantinno Capital Management LP | $1.577.892 | 73.152 | 0,67% | Aktien |
| CITADEL ADVISORS LLC | $1.382.529 | 64.095 | 0,58% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.357.573 | 62.938 | 0,57% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $1.354.184 | 62.781 | 0,57% | Aktien |
| SEI INVESTMENTS CO | $1.027.834 | 47.651 | 0,43% | Aktien |
| ALPS ADVISORS INC | $1.015.365 | 47.073 | 0,43% | Aktien |
| Williams Jones Wealth Management, LLC. | $901.626 | 41.800 | 0,38% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $831.847 | 38.565 | 0,35% | Aktien |
| Squarepoint Ops LLC | $798.112 | 37.001 | 0,34% | Aktien |
| US BANCORP \DE\ | $715.175 | 33.156 | 0,30% | Aktien |
| Nuveen, LLC | $653.959 | 30.318 | 0,28% | Aktien |
| HSBC HOLDINGS PLC | $634.793 | 29.539 | 0,27% | Aktien |
| Daiwa Securities Group Inc. | $629.218 | 29.171 | 0,27% | Aktien |
| Creative Planning | $624.487 | 28.952 | 0,26% | Aktien |
| MARSHALL WACE, LLP | $502.193 | 23.282 | 0,21% | Aktien |
| Empirical Finance, LLC | $431.400 | 20.000 | 0,18% | Aktien |
| Invesco Ltd. | $429.847 | 19.928 | 0,18% | Aktien |
| Cove Street Capital, LLC | $417.063 | 32.634 | 0,18% | Aktien |
| OSAIC HOLDINGS, INC. | $389.338 | 18.050 | 0,16% | Aktien |
| AMERIPRISE FINANCIAL INC | $366.928 | 17.007 | 0,15% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $351.591 | 16.300 | 0,15% | Verkaufsoption |
| ALLIANCEBERNSTEIN L.P. | $321.007 | 18.905 | 0,14% | Aktien |
Aktivisten & 5%+-Eigentümer 6 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Common Property Trust, Common Property Trust LLC, Amandla, LLC, Beans Patrick E., Hays Michael D. ×3 Einreichungen | 12. Juni 2026 | 45,70% | Änderung | · | SEC |
| Thomas Richardson, as the Trustee of Common Property Trust and as Manager of Common Property Trust LLC, Common Property Trust, Common Property Trust LLC ( ×2 Einreichungen | 5. März 2024 | · | Erste Einreichung | · | SEC |
| Patrick E. Beans, as the Special Holdings Direction Adviser under the Amandla MK Trust, Amandla MK Trust ×9 Einreichungen | 4. Januar 2024 | · | Erste Einreichung | · | SEC |
| Patrick E. Beans, as the Special Holdings Direction Adviser under the K/I/E Trust Under Agreement 10/24/18, K/I/E Trust Under Agreement 10/24/18 | 15. März 2021 | · | Erste Einreichung | · | SEC |
| Kent E. Endacott, as the Special Holdings Direction Adviser under the K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009), K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009) | 25. April 2018 | · | Erste Einreichung | · | SEC |
| Kent E. Endacott, as the Special Holdings Direction Adviser under the Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009, Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009 | 14. Juni 2013 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 27 Insider · 13 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Trent S Green | Chief Executive Officer | 1. Juni 2025 A | 500.000 | 0 | 0 | $0 |
| Shane R Harrison | EVP & Chief Financial Officer | 17. Februar 2026 P | 8.000 | 1 | 0 | $98.160 |
| Kevin R Karas | SVP Finance, CFO, Treas & Secy | 28. Februar 2023 S | 5.384 | 0 | 0 | $0 |
| Steven D. Jackson | President | 1. Oktober 2020 F | 55.567 | 0 | 0 | $0 |
| Susan L Henricks | President and COO | 7. Januar 2014 A | 7.823 | 0 | 0 | $0 |
| Joseph W Carmichael | President | 9. Mai 2008 F | 41.872 | 0 | 0 | $0 |
| Helen Hrdy | EVP & Chief Operating Officer | 15. Dezember 2025 M | 140.518 | 0 | 0 | $0 |
| Jona S Raasch | COO, NRC Health | 3. April 2023 S | 1.688 | 0 | 0 | $0 |
| Jason Russell Rau | Executive Vice President | 12. März 2026 A | 60.000 | 0 | 0 | $0 |
| David Burik | EVP, Strategic Insights | 5. Januar 2026 A | 100.000 | 0 | 0 | $0 |
| Hays Michael D. | Chairman | 5. Januar 2026 M | 20.154 | 0 | 0 | $0 |
| Jordan Nicole Freeman | Chief Accounting Officer | 31. Juli 2025 P | 771 | 0 | 0 | $0 |
| Andrew Monnich | Chief Corp. Development Off. | 7. April 2025 A | 100.000 | 0 | 0 | $0 |
| Parul Bhandari | Direktor | 23. Juni 2026 A | 7.697 | 0 | 0 | $0 |
| Penny Ann Wheeler | Direktor | 23. Juni 2026 A | 7.697 | 0 | 0 | $0 |
| Stephen H Lockhart | Direktor | 23. Juni 2026 A | 7.697 | 0 | 0 | $0 |
| Donald M Berwick | Direktor | 23. Juni 2026 A | 7.697 | 0 | 0 | $0 |
| John N Nunnelly | Direktor | 23. Juni 2026 A | 40.363 | 0 | 0 | $0 |
| Joann M Martin | Direktor | 29. Juni 2021 A | 138.955 | 0 | 0 | $0 |
| Barbara Mowry | Direktor | 15. Mai 2020 M | 42.902 | 0 | 0 | $0 |
| Gail L Warden | Direktor | 9. Mai 2017 A | 10.263 | 0 | 0 | $0 |
| Paul C Schorr III | Direktor | 28. Oktober 2013 G | 34.802 | 0 | 0 | $0 |
| Beans Patrick E. | 10%-Eigentümer | 12. Mai 2025 P | 35.003 | 0 | 0 | $0 |
| Common Property Trust | 10%-Eigentümer | 31. Dezember 2024 G | 4.755.317 | 0 | 0 | $0 |
| Amandla MK Trust | 10%-Eigentümer | 31. Dezember 2024 G | 0 | 0 | 0 | $0 |
| Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009 | 10%-Eigentümer | 11. März 2021 S | 0 | 0 | 0 | $0 |
| Karen S Hays | 10%-Eigentümer | 12. Februar 2010 G | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 21 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| ROSC · Lattice Strategies Trust | 0,38% | 12.032 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 40.256 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 111.072 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 13.354 SH | 1. Oktober 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 68.097 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 12.633 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 301.953 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 62.228 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 5.634 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 560 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 2.149 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.985 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 17.485 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 4.118 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 23.452 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 3.867 SH | 3. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 2.478 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 151.126 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 498.279 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 995 SH | 19. August 2026 | Täglich |
| SMLF · iShares Trust | · | 66.767 SH | 11. September 2026 | Täglich |
NRC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 5 Analysten
KAUF
Median-Ziel
$26.00
+27,8%
1 20,0%
Starker Kauf
3 60,0%
Kauf
1 20,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
1 Analysten · 2026-09-27Mittelwert-Ziel $26.00 +27,8%
Tief$26.00
Mittelwert$26.00
Hoch$26.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
US Nuclear Regulator Seeks Simpler Environmental Reviews To Boost Nuclear Expansion
ZeroHedge · 2 Monate, 3 Wochen vor
Die besten Aktien im Nuklearbereich, die Sie für Jahrzehnte kaufen und halten sollten
Nasdaq · 4 Monate vor
In 10 Jahren, werden Sie es bereuen, NuScale Power Aktie nicht jetzt gekauft zu haben?
Nasdaq · 4 Monate, 3 Wochen vor
Oklo im Vergleich zu NuScale Power: Beide fallen 2026, aber nur einer ist jetzt wertvoll zu kaufen
Nasdaq · 5 Monate vor
New Jersey Gouverneurin Sherrill hebt 40-jährige Atomkraft-Moratorium auf
ZeroHedge · 5 Monate, 3 Wochen vor
Diese Atomenergie-Aktie für 10 US-Dollar könnte Ihr Ticket zum Millionärsstatus sein
Nasdaq · 5 Monate, 3 Wochen vor
NuScale Power ist um 80 % gefallen -- das ist eine gute Nachricht für langfristige Anleger
Nasdaq · 5 Monate, 4 Wochen vor
"Ein entscheidender Moment": Nano Nuclear reicht Baugenehmigung für Kronos-Reaktor in Illinois ein
ZeroHedge · 6 Monate vor
Oklo sichert sich eine NRC-Lizenz. Sollten Sie hier Aktien von OKLO kaufen?
Yahoo Finance · 6 Monate, 1 Woche vor
"Nachfrage nach kritischen Isotopen steigt, Angebot begrenzt": Oklo erhält erste NRC-Lizenz und weiteren DOE-Meilenstein
ZeroHedge · 6 Monate, 2 Wochen vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 4, 2026